SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-21-057650
Filing Date
2021-11-18
Accepted
2021-11-18 17:00:34
Documents
14
Period of Report
2021-11-17
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K odt-8k_20211117.htm   iXBRL 8-K 34337
2 EX-99 odt-ex99_6.htm EX-99 4364
3 GRAPHIC griuzardhedr000001.jpg GRAPHIC 42850
  Complete submission text file 0001564590-21-057650.txt   231098

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA odt-20211117.xsd EX-101.SCH 5678
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE odt-20211117_lab.xml EX-101.LAB 20065
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE odt-20211117_pre.xml EX-101.PRE 11929
7 EXTRACTED XBRL INSTANCE DOCUMENT odt-8k_20211117_htm.xml XML 3677
Mailing Address 3 EAST 28TH STREET 10TH FLOOR NEW YORK NY 10016
Business Address 3 EAST 28TH STREET 10TH FLOOR NEW YORK NY 10016 332-206-0935
Odonate Therapeutics, Inc. (Filer) CIK: 0001717452 (see all company filings)

IRS No.: 822493065 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38318 | Film No.: 211425154
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences